Nabil Wasif
Papers
2
Total Citations
17
H-Index
2
About
Dr. Nabil Wasif is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for complex abdominal cancers, particularly through robotic-assisted surgery. His major contributions center on expanding the role of robotics in high-risk, multi-step procedures, such as cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) and pancreaticoduodenectomy with vascular reconstruction. His 2018 work on robotic-assisted CRS-HIPEC, which has garnered 15 citations, was among the first to demonstrate the feasibility and safety of this approach for peritoneal surface malignancies, offering patients reduced recovery times without compromising oncologic outcomes. More recently, his 2025 paper on robotic pancreatoduodenectomy with segmental portomesenteric venous resection and primary end-to-end reconstruction showcases a novel technique for achieving a tension-free anastomosis in locally advanced pancreatic cancer—a procedure traditionally requiring open surgery. Dr. Wasif’s work is notable for pushing the boundaries of what is possible robotically, directly impacting surgical training and patient care. His publications, though early in citation accrual, are already influencing practice patterns in high-volume centers, marking him as a pioneer in the next generation of oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2